These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8612232)

  • 1. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy.
    Preul MC; Caramanos Z; Collins DL; Villemure JG; Leblanc R; Olivier A; Pokrupa R; Arnold DL
    Nat Med; 1996 Mar; 2(3):323-5. PubMed ID: 8612232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo 1H-spectroscopy of human intracranial tumors at 1.5 tesla. Preliminary experience at a clinical installation.
    Henriksen O; Wieslander S; Gjerris F; Jensen KM
    Acta Radiol; 1991 Mar; 32(2):95-9. PubMed ID: 2031809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
    AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging brain tumors -- beyond three dimensions.
    Laws ER
    Nat Med; 1996 Mar; 2(3):271-2. PubMed ID: 8612217
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo proton magnetic resonance spectroscopy of brain tumors.
    Fountas KN; Kapsalaki EZ; Gotsis SD; Kapsalakis JZ; Smisson HF; Johnston KW; Robinson JS; Papadakis N
    Stereotact Funct Neurosurg; 2000; 74(2):83-94. PubMed ID: 11251398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Preul MC; Caramanos Z; Villemure JG; Shenouda G; LeBlanc R; Langleben A; Arnold DL
    Neurosurgery; 2000 Feb; 46(2):306-18. PubMed ID: 10690719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
    Felber SR
    Radiologe; 1993 Nov; 33(11):626-32. PubMed ID: 8278589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
    McKnight TR
    Semin Oncol; 2004 Oct; 31(5):605-17. PubMed ID: 15497114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrimination of brain abscess and cystic tumor by in vivo proton magnetic resonance spectroscopy.
    Kadota O; Kohno K; Ohue S; Kumon Y; Sakaki S; Kikuchi K; Miki H
    Neurol Med Chir (Tokyo); 2001 Mar; 41(3):121-6. PubMed ID: 11372554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo hydrogen-1 magnetic resonance spectroscopy study of human intracranial tumors.
    Luan W; Zhang J
    Chin Med J (Engl); 1998 Jan; 111(1):56-8. PubMed ID: 10322655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.
    Sibtain NA; Howe FA; Saunders DE
    Clin Radiol; 2007 Feb; 62(2):109-19. PubMed ID: 17207692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible role of single-voxel (1)H-MRS in differential diagnosis of suprasellar tumors.
    Chernov MF; Kawamata T; Amano K; Ono Y; Suzuki T; Nakamura R; Muragaki Y; Iseki H; Kubo O; Hori T; Takakura K
    J Neurooncol; 2009 Jan; 91(2):191-8. PubMed ID: 18825316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy (MRS) of metastatic brain tumors: variations of metabolic profile.
    Chernov MF; Hayashi M; Izawa M; Ono Y; Hori T
    Int J Clin Oncol; 2006 Oct; 11(5):375-84. PubMed ID: 17058135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
    Galanaud D; Nicoli F; Le Fur Y; Roche P; Confort-Gouny S; Dufour H; Ranjeva JP; Peragut JC; Viout P; Cozzone PJ
    Ann Med Interne (Paris); 2002 Dec; 153(8):491-8. PubMed ID: 12610422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas.
    Pfisterer WK; Nieman RA; Scheck AC; Coons SW; Spetzler RF; Preul MC
    Neurosurg Focus; 2010 Jan; 28(1):E12. PubMed ID: 20043716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of voxel position on single-voxel MR spectroscopy findings.
    Ricci PE; Pitt A; Keller PJ; Coons SW; Heiserman JE
    AJNR Am J Neuroradiol; 2000 Feb; 21(2):367-74. PubMed ID: 10696025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors.
    Astrakas LG; Zurakowski D; Tzika AA; Zarifi MK; Anthony DC; De Girolami U; Tarbell NJ; Black PM
    Clin Cancer Res; 2004 Dec; 10(24):8220-8. PubMed ID: 15623597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized proton spectroscopy of focal brain pathology in humans: significant effects of edema on spin-spin relaxation time.
    Kamada K; Houkin K; Hida K; Matsuzawa H; Iwasaki Y; Abe H; Nakada T
    Magn Reson Med; 1994 May; 31(5):537-40. PubMed ID: 8015407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
    Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
    Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.
    Hazany S; Hesselink JR; Healy JF; Imbesi SG
    Neuroradiology; 2007 Feb; 49(2):121-7. PubMed ID: 17086406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.